{"id":27597,"date":"2024-01-19T18:09:41","date_gmt":"2024-01-19T23:09:41","guid":{"rendered":"https:\/\/www.ipoboutique.com\/blog\/?p=27597"},"modified":"2024-01-19T18:09:41","modified_gmt":"2024-01-19T23:09:41","slug":"pipeline-update-four-ipos-on-the-schedule-filings-trickle-in","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/pipeline-update-four-ipos-on-the-schedule-filings-trickle-in\/","title":{"rendered":"Pipeline Update: Four IPOs on the Schedule; Filings trickle in"},"content":{"rendered":"<p dir=\"ltr\"><b><u>NEW FILINGS<\/u><\/b><\/p>\n<p dir=\"ltr\">Company: Kyverna Therapeutcs, Inc.<\/p>\n<p dir=\"ltr\">Symbol: KYTX (Nasdaq)<\/p>\n<p dir=\"ltr\">Description: They are a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases.<\/p>\n<p dir=\"ltr\">Shares: TBD<\/p>\n<p dir=\"ltr\">Price Range: TBD<\/p>\n<p dir=\"ltr\">Trade Date:\u00a0 TBD<\/p>\n<p dir=\"ltr\">Underwriters: JP Morgan, Morgan Stanley, Leerink Partners, Wells Fargo<\/p>\n<p dir=\"ltr\">Link to Prospectus: <a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1994702\/000119312524008614\/d530411ds1.htm\">Filed: 1-16-24<\/a><\/p>\n<p dir=\"ltr\">\n<p dir=\"ltr\">Company: BBB Foods Inc.<\/p>\n<p dir=\"ltr\">Symbol: TBBB (NYSE)<\/p>\n<p dir=\"ltr\">Description: They are pioneers and leaders of the grocery hard discount model in Mexico and one of the fastest growing retailers in the country as measured by our sales and store growth rates.<\/p>\n<p dir=\"ltr\">Shares: TBD<\/p>\n<p dir=\"ltr\">Price Range: TBD<\/p>\n<p dir=\"ltr\">Trade Date:\u00a0 TBD<\/p>\n<p dir=\"ltr\">Underwriters: JP Morgan, Morgan Stanley, BofA Securities, ScotiaBank, UBS Investment Bank<\/p>\n<p dir=\"ltr\">Link to Prospectus: <a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1978954\/000119312524010259\/d632766df1.htm\">Filed: 1-18-24<\/a><\/p>\n<p>&nbsp;<\/p>\n<p dir=\"ltr\"><img decoding=\"async\" src=\"https:\/\/lh7-us.googleusercontent.com\/FejMxEZ8DFUxaSmrN4RfEYgxWt6y3Bp5XVOxNr2nXmij43YXp2YX8mbPCvPnBP0RZDYAZiMbdi7x6mJpTkx4z8MWbXZoreWTpH_fKOFJM-02kf5q-TeHvWyTw_-UtRznJO4ff94gT2SG3EdrnGie-hM\" width=\"156\" height=\"107\" \/><\/p>\n<p><b><u>\u00a0<\/u><\/b><\/p>\n<p dir=\"ltr\"><b><u>TERMS ADDED:<\/u><\/b><\/p>\n<p dir=\"ltr\">Company: CG Oncology, Inc<\/p>\n<p dir=\"ltr\">Symbol: CGON (Nasdaq)<\/p>\n<p dir=\"ltr\">Description: They are a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer.<\/p>\n<p dir=\"ltr\">Shares: 11.8 million<\/p>\n<p dir=\"ltr\">Price Range: $16.00-$18.00<\/p>\n<p dir=\"ltr\">Market Cap: $885m-$1.0b<\/p>\n<p dir=\"ltr\">Trade Date:\u00a0 Thursday, 1\/25<\/p>\n<p dir=\"ltr\">Underwriters: Morgan Stanley, Goldman Sachs, Cantor<\/p>\n<p dir=\"ltr\">Co-Managers: LifeSci Capital<\/p>\n<p dir=\"ltr\">Link to Prospectus: <a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1991792\/000119312524009621\/d551455ds1a.htm\">Terms Added: 1-18-24<\/a><\/p>\n<p>&nbsp;<\/p>\n<p dir=\"ltr\"><img decoding=\"async\" src=\"https:\/\/lh7-us.googleusercontent.com\/ULWMuygG1ZPyHafudp3WsQP1AZROsZbJzgki3a28fXthzxlFJ1CTe2muQtkd9yc66XkTUbNKlWveG9hyYD-iYdwqMVUeprFvcJX6jvPc2Pkn-6wPT-5dptqx4MiL18nsBcMzGG47ihi49agN0sNTr3E\" width=\"433\" height=\"101\" \/><\/p>\n<p>&nbsp;<\/p>\n<p dir=\"ltr\">Company: BrightSpring Health Services, Inc.<\/p>\n<p dir=\"ltr\">Symbol: BTSG (Nasdaq)<\/p>\n<p dir=\"ltr\">Description: They are a leading home and community-based healthcare services platform, focused on delivering complementary provider and pharmacy services to complex patients.<\/p>\n<p dir=\"ltr\">Shares: 53.3 million<\/p>\n<p dir=\"ltr\">Price Range: $15.00-$18.00<\/p>\n<p dir=\"ltr\">Market Cap: $2.6b-$3.1b<\/p>\n<p dir=\"ltr\">Trade Date:\u00a0 Friday, 1\/26<\/p>\n<p dir=\"ltr\">Underwriters: Goldman Sachs, KKR, Jefferies, Morgan Stanley, UBS, BofA Securities, Leerink Partners, Wells Fargo, Deutsche Bank, HSBC, Mizuho, BMO Capital Markets, Loop Capital Markets<\/p>\n<p dir=\"ltr\">Link to Prospectus:<a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1865782\/000119312524008939\/d251968ds1a.htm\"> Terms Added: 1-17-24<\/a><\/p>\n<p>&nbsp;<\/p>\n<p dir=\"ltr\"><img decoding=\"async\" src=\"https:\/\/lh7-us.googleusercontent.com\/MrNKO4VFcf4eAVthJZ1Rn1TKSOGSfxtv5Y7bXg3vA24gljG0b6iCsXd0KLwBL_bU9ENHgVMwvgSLGGe_rRWkpE5hQxYXhIXTf-Hg3iI9UAfgFQdxpxWWgbHI8dR5ob-p9YGWMbxTk57SDn934wc91Q\" width=\"283\" height=\"74\" \/><\/p>\n<p>&nbsp;<\/p>\n<p dir=\"ltr\">Company: Morgan Stanley Direct Lending Fund<\/p>\n<p dir=\"ltr\">Symbol: MSDL (NYSE)<\/p>\n<p dir=\"ltr\">Description:\u00a0 They are a non-diversified, externally managed specialty finance company focused on lending to middle-market companies.<\/p>\n<p dir=\"ltr\">Shares: 5.0 million<\/p>\n<p dir=\"ltr\">Price Range: $20.67-$20.67<\/p>\n<p dir=\"ltr\">Market Cap: $1.8b-$1.8b<\/p>\n<p dir=\"ltr\">Trade Date:\u00a0 Thursday, 1\/25<\/p>\n<p dir=\"ltr\">Underwriters: Morgan Stanley, JP Morgan,\u00a0 Wells Fargo, Keefe Bruyette &amp; Woods, Raymond James, RBC Capital, UBS Investment Bank<\/p>\n<p dir=\"ltr\">Co-Manager(s): ING, JMP Securities, MUFG, SMBC\u00a0 Nikko, Academy Securities, Loop Capital, R Seelaus &amp; Co., Ramirez &amp; Co.<\/p>\n<p dir=\"ltr\">Link to Prospectus:\u00a0 <a href=\"https:\/\/www.sec.gov\/ix?doc=\/Archives\/edgar\/data\/1782524\/000110465924004109\/none-20240116xn2a.htm\">Filed: 1-16-24<\/a><\/p>\n<p>&nbsp;<\/p>\n<p dir=\"ltr\">Company: Nuveen Churchill Direct Lending Corp.<\/p>\n<p dir=\"ltr\">Symbol: NCDL (NYSE)<\/p>\n<p dir=\"ltr\">Description:\u00a0 They are a specialty finance company focused primarily on investing in senior secured loans to private equity-owned U.S. middle market companies.<\/p>\n<p dir=\"ltr\">Shares: 5.5 million<\/p>\n<p dir=\"ltr\">Price Range: $18.05-$18.05<\/p>\n<p dir=\"ltr\">Market Cap: $990m-$990m<\/p>\n<p dir=\"ltr\">Trade Date:\u00a0 Thursday, 1\/25<\/p>\n<p dir=\"ltr\">Underwriters: BofA Securities, UBS Investment Bank, Morgan Stanley, Wells Fargo, Keefe Bruyette &amp; Woods, JMP Securities, Truist Securities<\/p>\n<p dir=\"ltr\">Co-Manager(s): MUFG, SMBC Securities, Academy Securities, Blaylock Van LLC<\/p>\n<p dir=\"ltr\">Link to Prospectus:\u00a0 <a href=\"https:\/\/www.sec.gov\/ix?doc=\/Archives\/edgar\/data\/1737924\/000162828024001287\/ck0001737924-20240116.htm\">Filed: 1-16-24<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>NEW FILINGS Company: Kyverna Therapeutcs, Inc. Symbol: KYTX (Nasdaq) Description: They are a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. Shares: TBD Price Range: TBD Trade Date:\u00a0 TBD Underwriters: JP Morgan, Morgan Stanley, Leerink Partners, Wells Fargo Link to Prospectus: Filed: 1-16-24 Company: BBB Foods Inc. Symbol:[&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":null,"zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":null,"zakra_breadcrumbs_separator_color":null,"zakra_breadcrumbs_link_color":null,"zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[1536],"tags":[],"class_list":["post-27597","post","type-post","status-publish","format-standard","hentry","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/27597","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=27597"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/27597\/revisions"}],"predecessor-version":[{"id":27598,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/27597\/revisions\/27598"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=27597"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=27597"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=27597"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}